-
2025-521188-11-00
5
2025-10-15
Type 2 diabetes
-
2025-521147-21-00
4
2025-10-08
Lung Cancer
-
2024-517780-24-00
5
2025-09-18
Lung Cancer
-
2024-515698-85-00
5
2025-06-12
Locally Advanced or Metastatic Non-small Cell Lung Cancer
-
2024-514689-38-01
4
2025-05-12
Pain Associated With Diabetic Peripheral Neuropathy
-
2024-515793-27-01
5
2025-04-30
HIV
-
2024-516456-17-00
5
2024-05-07
patients admitted for an obstructive colon cancer
-
2022-501057-36-00
5
2023-10-24
ANCA-associated vasculitis
-
2024-515945-40-00
10
2022-05-02
Non small cell lung cancer
-
2023-508922-83-00
10
2021-03-17
Advanced Non-Small Cell Lung Cancer
-
2025-521681-10-00
4
2025-10-02
Lung Cancer
-
2024-512998-27-00
5
2025-02-21
Non-Small Cell Lung Cancer
-
2023-504753-12-00
5
2024-10-01
Lung Cancer, Non-Small Cell
-
2023-509825-38-00
5
2022-12-01
Metastatic Non–Small Cell Lung Cancer
-
2024-512378-91-00
4
2022-06-24
Unresectable or Advanced Melanoma
-
2024-516914-39-00
5
2022-04-27
Metastatic or unresectable melanoma
-
2024-512148-50-00
5
2022-03-03
Non-small cell lung cancer
-
2024-512028-12-00
4
2021-03-19
Advanced ROS1-positive non-small cell lung cancer
-
2024-515944-22-00
4
2021-01-19
BRAFV600E-mutant metastatic Non-small Cell Lung Cancer
-
2024-511653-22-00
5
2020-02-12
Cutaneous Squamous Cell Carcinoma (CSCC)
-
2024-515946-17-00
5
2019-07-22
Non Small Cell Lung Cancer
-
2022-501183-17-00
7
2023-02-23
Non-Small Cell Lung Cancer
-
2024-511996-13-00
5
2022-05-11
Previously untreated, unresectable, or metastatic melanoma
-
2024-516100-42-00
4
2022-03-18
Melanoma